Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0R5OE
|
||||
| Former ID |
DNC007343
|
||||
| Drug Name |
(S)-pyrrolidin-2-yl(thiazolidin-3-yl)methanone
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C8H14N2OS
|
||||
| Canonical SMILES |
C1CC(NC1)C(=O)N2CCSC2
|
||||
| InChI |
1S/C8H14N2OS/c11-8(7-2-1-3-9-7)10-4-5-12-6-10/h7,9H,1-6H2/t7-/m0/s1
|
||||
| InChIKey |
GTTPYCGIEGLJPF-ZETCQYMHSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Dipeptidyl peptidase IV | Target Info | Inhibitor | [1] | |
| KEGG Pathway | Protein digestion and absorption | ||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| TGF_beta_Receptor Signaling Pathway | |||||
| References | |||||
| REF 1 | Bioorg Med Chem Lett. 2007 May 1;17(9):2618-21. Epub 2007 Feb 8.[(S)-gamma-(4-Aryl-1-piperazinyl)-l-prolyl]thiazolidines as a novel series of highly potent and long-lasting DPP-IV inhibitors. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.